
Understanding adverse events related to perioperative immunotherapy: A primer for thoracic surgeons
Author(s) -
Jones David R.
Publication year - 2021
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.14097
Subject(s) - medicine , oncology , lung cancer , adverse effect , perioperative , chemotherapy , nivolumab , clinical trial , neoadjuvant therapy , durvalumab , cancer , intensive care medicine , surgery , immunotherapy , breast cancer